Thymopentin in the treatment of juvenile chronic arthritis

M. Bardare, F. Corona, M. T. Ogliari, E. Cohen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

An immunological imbalance is probably one of the major pathogenetic causes of rheumatoid arthritis in adults as well as in children. This aspect is the rationale for the use of immuno-modulating drugs. In our study we evaluated the effects of intravenously administered thymopentin on systemic and local features in 10 children affected with systemic onset juvenile chronic arthritis (JCA). We also considered the effects of intra-articular thymopentin in 3 children affected with pauciarticular onset JCA.

Original languageEnglish
Pages (from-to)89-93
Number of pages5
JournalClinical and Experimental Rheumatology
Volume8
Issue number1
Publication statusPublished - 1990

Fingerprint

Thymopentin
Juvenile Arthritis
Rheumatoid Arthritis
Therapeutics
Joints
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Thymopentin in the treatment of juvenile chronic arthritis. / Bardare, M.; Corona, F.; Ogliari, M. T.; Cohen, E.

In: Clinical and Experimental Rheumatology, Vol. 8, No. 1, 1990, p. 89-93.

Research output: Contribution to journalArticle

Bardare, M, Corona, F, Ogliari, MT & Cohen, E 1990, 'Thymopentin in the treatment of juvenile chronic arthritis', Clinical and Experimental Rheumatology, vol. 8, no. 1, pp. 89-93.
Bardare, M. ; Corona, F. ; Ogliari, M. T. ; Cohen, E. / Thymopentin in the treatment of juvenile chronic arthritis. In: Clinical and Experimental Rheumatology. 1990 ; Vol. 8, No. 1. pp. 89-93.
@article{578f58bd396b42c69d08147030930741,
title = "Thymopentin in the treatment of juvenile chronic arthritis",
abstract = "An immunological imbalance is probably one of the major pathogenetic causes of rheumatoid arthritis in adults as well as in children. This aspect is the rationale for the use of immuno-modulating drugs. In our study we evaluated the effects of intravenously administered thymopentin on systemic and local features in 10 children affected with systemic onset juvenile chronic arthritis (JCA). We also considered the effects of intra-articular thymopentin in 3 children affected with pauciarticular onset JCA.",
author = "M. Bardare and F. Corona and Ogliari, {M. T.} and E. Cohen",
year = "1990",
language = "English",
volume = "8",
pages = "89--93",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "1",

}

TY - JOUR

T1 - Thymopentin in the treatment of juvenile chronic arthritis

AU - Bardare, M.

AU - Corona, F.

AU - Ogliari, M. T.

AU - Cohen, E.

PY - 1990

Y1 - 1990

N2 - An immunological imbalance is probably one of the major pathogenetic causes of rheumatoid arthritis in adults as well as in children. This aspect is the rationale for the use of immuno-modulating drugs. In our study we evaluated the effects of intravenously administered thymopentin on systemic and local features in 10 children affected with systemic onset juvenile chronic arthritis (JCA). We also considered the effects of intra-articular thymopentin in 3 children affected with pauciarticular onset JCA.

AB - An immunological imbalance is probably one of the major pathogenetic causes of rheumatoid arthritis in adults as well as in children. This aspect is the rationale for the use of immuno-modulating drugs. In our study we evaluated the effects of intravenously administered thymopentin on systemic and local features in 10 children affected with systemic onset juvenile chronic arthritis (JCA). We also considered the effects of intra-articular thymopentin in 3 children affected with pauciarticular onset JCA.

UR - http://www.scopus.com/inward/record.url?scp=0025233895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025233895&partnerID=8YFLogxK

M3 - Article

C2 - 1971780

AN - SCOPUS:0025233895

VL - 8

SP - 89

EP - 93

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 1

ER -